Eisai
HALAVEN
Manufacturer:
Eisai
Name:
HALAVEN
HCPCS Code Descriptor:
Injection, eribulin mesylate, 0.1 mg
Category:
J Code
HCPCS:
J9179
NDC(s):
62856-0389-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
HALAVEN is an Oncology drug manufactured by Eisai and administered via the Intravenous route of administration. The J Code: J9179 is aligned to the drug HALAVEN.